Mepolizumab in Episodic Angioedema With Eosinophilia
Clinical trial NCT04128371 · TERMINATED
Trial details
- NCT number
- NCT04128371
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-14
- Primary completion
- 2022-10-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.